hit counter

Alzheimer’s Amyloid Plaques Recruit CD8 T Cells Through Type I Interferon

MHD featured image for Alzheimer's amyloid plaques, CD8 T cells, type I interferon, and CXCL10 signaling.

A 2026 single-cell and spatial-transcriptomics study of 21,156 brain immune cells found that late amyloid disease shifted interferon-driven neuroinflammation from microglia toward plaque-associated CD8 T cells, with T-cell frequency strongly tracking total amyloid deposits (Spearman rho = 0.844, p < 0.0001).1 The result does not turn Alzheimer’s disease into an autoimmune disease, but it makes …

Read more

Open ICU Visiting Reduced Delirium and Anxiety in Chronic Critical Patients

MHD featured image for open ICU visiting, delirium, anxiety, and chronic critical illness.

A 2026 retrospective ICU study found that 24-hour family visiting was associated with lower delirium in chronic critical patients than 1-hour restricted visiting: 11.36% vs. 25.76%.1 The same open-visiting group also had lower discharge HADS anxiety-depression scores, shorter ventilation, and no measurable worsening in sampled ICU air quality, but the time-based single-center design keeps the …

Read more

Low-Level Lead Linked to Infant Neurodevelopment Through DNA Methylation

MHD featured image for low-level lead exposure, infant neurodevelopment, and FAM50B/PTCHD3 DNA methylation.

A 2026 prospective birth-cohort study in southern China linked mean cord-blood lead of 15.30 μg/L to lower infant neurodevelopmental scores across all 5 Ages and Stages Questionnaire domains, even though only 1.13% of samples exceeded 50 μg/L.1 A second finding was mechanistic: part of the lead-development association statistically ran through FAM50B/PTCHD3 DNA methylation, an epigenetic …

Read more

Multiple Sclerosis Frailty Exercise Improved Fatigue in 6 Weeks

MHD featured image for multimodal exercise, frailty, fatigue, and quality of life in multiple sclerosis.

A 2026 pilot randomized trial in 16 frail adults with multiple sclerosis found that 6 weeks of supervised multimodal exercise was feasible: retention was 87.5%, adherence was 97.2%, no adverse events were recorded, and fatigue and quality-of-life scores moved more than they did with waitlist control.1 Research Highlights Feasibility cleared the prespecified bar: 14 of …

Read more

Levetiracetam After Stroke: 9 Fewer Deaths in Older Adults

MHD featured image for levetiracetam continuation, post-stroke seizure prevention, and 90-day survival in older adults.

A 2026 Medicare target-trial emulation found continued levetiracetam after acute ischemic stroke was associated with 53 vs. 62 deaths per 1,000 over 90 days, a risk difference of −9 deaths per 1,000 favoring continuation. Research Highlights Survival signal: continued levetiracetam after an initial month of post-stroke use was linked to 53 deaths per 1,000 vs. …

Read more

Dysarthria Speech Biomarker Tracked Severity Across 5 Languages

MHD featured image for dysarthria speech biomarkers, phonological subspace collapse, and cross-language severity tracking.

A 2026 medRxiv preprint found that a training-free speech biomarker tracked dysarthria severity across 890 speakers, 10 corpora, and 5 full-pipeline languages, with all 5 consonant d-prime features showing random-effects correlations with clinical severity (rho = −0.50 to −0.56; all p < 2e−4). Research Highlights Speech-severity signal was broad: Muller et al. evaluated 890 speakers …

Read more

Serum MOG Blood Biomarker Rose During Multiple Sclerosis Relapse

MHD featured image for serum MOG blood biomarker levels and multiple sclerosis relapse activity.

A 2026 medRxiv case-control study found that serum myelin oligodendrocyte glycoprotein was 20.5 pg/ml higher in multiple sclerosis than in healthy donors and 15.3 pg/ml higher during relapse than remission, making it a plausible blood marker of demyelination rather than a replacement for neurofilament light chain. Research Highlights MOG was higher in MS: serum myelin …

Read more